These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28760368)

  • 1. Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?
    Hogen L; Brar H; Covens A; Bassiouny D; Bernardini MQ; Gien LT; Ferguson SE; Vicus D
    Gynecol Oncol; 2017 Oct; 147(1):54-60. PubMed ID: 28760368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
    Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
    Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
    Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
    Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Chemotherapy, Laparoscopy, and Cytology on Stage IC Ovarian Clear Cell Carcinoma: A Long-Term, Single-Center Study.
    Chang HT; Chiu ML; Wang TY; Chen TC; Chang CL; Su TH; Wang KG; Wang KL; Yang YC; Chen JR
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
    Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
    Int J Clin Oncol; 2007 Aug; 12(4):256-60. PubMed ID: 17701003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin.
    Sirichaisutdhikorn D; Suprasert P; Khunamornpong S
    Asian Pac J Cancer Prev; 2009; 10(6):1041-5. PubMed ID: 20192580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of adjuvant paclitaxel and carboplatin for early-stage ovarian clear-cell carcinoma with complete surgical staging.
    Kajiyama H; Shibata K; Suzuki S; Ino K; Kawai M; Nagasaka T; Nawa A; Kikkawa F
    Gynecol Obstet Invest; 2011; 72(4):252-6. PubMed ID: 22041903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
    Takano M; Sugiyama T; Yaegashi N; Sagae S; Kuzuya K; Udagawa Y; Tsuda H; Suzuki M; Kigawa J; Goto T; Tsuda H; Moriya T; Kikuchi Y
    Int J Gynecol Cancer; 2010 Dec; 20(9):1506-10. PubMed ID: 21119366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma.
    Hogen L; Thomas G; Bernardini M; Bassiouny D; Brar H; Gien LT; Rosen B; Le L; Vicus D
    Gynecol Oncol; 2016 Nov; 143(2):258-263. PubMed ID: 27623251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
    Hoskins PJ; Le N; Gilks B; Tinker A; Santos J; Wong F; Swenerton KD
    J Clin Oncol; 2012 May; 30(14):1656-62. PubMed ID: 22493415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Oliver KE; Brady WE; Birrer M; Gershenson DM; Fleming G; Copeland LJ; Tewari K; Argenta PA; Mannel RS; Secord AA; Stephan JM; Mutch DG; Stehman FB; Muggia FM; Rose PG; Armstrong DK; Bookman MA; Burger RA; Farley JH
    Gynecol Oncol; 2017 Nov; 147(2):243-249. PubMed ID: 28807367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
    Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
    Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
    Shu CA; Zhou Q; Jotwani AR; Iasonos A; Leitao MM; Konner JA; Aghajanian CA
    Gynecol Oncol; 2015 Nov; 139(2):236-41. PubMed ID: 26404183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
    Chan JK; Tian C; Fleming GF; Monk BJ; Herzog TJ; Kapp DS; Bell J
    Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?
    Wang D; Xiang Y; Wu M; Shen K; Yang J; Huang H; Ren T
    J Ovarian Res; 2018 Mar; 11(1):25. PubMed ID: 29587835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.